查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585657

生物製藥第三方物流市場：按供應鏈、服務類型分類 - 全球預測 2025-2030

Biopharmaceutical Third Party Logistics Market by Supply Chain (Cold Chain, Non-Cold Chain), Service Type (Transportation, Warehousing & Storage) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生醫第三方物流市場規模為1,070.8億美元，預估2024年將達1,217.7億美元，複合年成長率為14.20%，2030年將達2,713.2億美元，預估將達1,000萬美元。

生物製藥第三方物流（3PL）市場在生物製藥的高效管理和分銷中發揮關鍵作用，包括針對溫度和時間敏感的藥品量身定做的倉儲、運輸和物流技術，提供端到端服務。全球藥品供應鏈日益複雜，並且需要遵守嚴格的監管標準，同時確保安全且有效率地交付高價值生技藥品，這推動了對這些服務的需求。應用涵蓋醫院、專科診所和藥房等各種最終用途領域，促進疫苗、單株抗體和其他生物製藥的分銷。該市場的成長是由對特種藥品的需求不斷成長、物流技術的進步（例如用於即時監控的物聯網和人工智慧）以及生物製藥產能的擴大所推動的。新的商機在於區塊鏈的整合，以提高供應鏈的透明度和安全性，隨著產業尋求降低風險和提高合規性，這一點變得越來越有吸引力。然而，其限制包括由於需要專門的基礎設施而導致營運成本較高，以及不同地區不斷變化的法規所帶來的複雜性。此外，許多生物製藥的利基性質需要單獨的儲存和運輸解決方案，並且擴充性仍然是一個挑戰。創新應著重於永續物流解決方案，旨在減少碳足跡，開發適應性低溫運輸解決方案，並加強預測物流規劃的資料分析能力。該市場本質上是競爭性的，其特點是物流提供商和生物製藥公司之間旨在最佳化其物流網路的戰略聯盟和合併。相關人員應優先投資技術主導的解決方案，以提高業務效率和服務差異化，同時專注於區域擴大策略，以開拓藥品需求不斷成長的新興市場。

主要市場統計
基準年[2023] 1070.8億美元
預測年份 [2024] 1217.7億美元
預測年份 [2030] 2713.2億美元
複合年成長率（%） 14.20%

市場動態：揭示快速發展的生物製藥第三方物流市場的關鍵市場洞察

供需的動態交互作用正在改變生物製藥第三方物流市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 製藥和生物製藥行業的研發 (R&D) 支出不斷增加
    • 對運輸生技藥品的溫控物流服務的需求不斷成長
    • 各醫療機構外包物流上升趨勢
  • 市場限制因素
    • 藥物開發和藥物發現程序的高成本
  • 市場機會
    • 生物製藥第三方物流解決方案的技術進步不斷進步
    • 對生物相似藥的需求迅速增加
  • 市場挑戰
    • 關於國際物流程序的嚴格政府規章制度

波特五力：駕馭生物製藥第三方物流市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物製藥第三方物流市場的外部影響

外部宏觀環境因素對生物製藥第三方物流市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物製藥第三方物流市場競爭格局

對生物製藥第三方物流市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 生物製藥第三方物流市場中的定位矩陣供應商績效評估

FPNV定位矩陣是評估生物製藥第三方物流市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議描繪生物製藥第三方物流市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生物製藥第三方物流市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫藥及生技製藥產業研發費用增加
      • 運送生技藥品時對溫控物流服務的需求不斷增加
      • 各醫療機構物流外包新趨勢
    • 抑制因素
      • 藥物開發和藥物發現程序的高成本
    • 機會
      • 擴大生物製藥第三方物流解決方案的技術進步
      • 生物相似藥需求快速成長
    • 任務
      • 關於國際物流程序的嚴格政府規章制度
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 生物醫藥第三方物流市場供應鏈

  • 低溫運輸
  • 非低溫運輸

第7章生物製藥第三方物流市場：依服務類型

  • 運輸
    • 空運
    • 陸上
    • 海運
  • 倉儲

第8章美洲生物製藥第三方物流市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太生物醫藥第三方物流市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲生物製藥第三方物流市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agility Public Warehousing Company KSCP
  • AmerisourceBergen Corporation
  • CH Robinson Worldwide, Inc.
  • CEVA Logistics AG
  • DB Schenker
  • DHL International GmbH
  • FedEx Corporation
  • Hitachi Transport System, Ltd.
  • Kerry Logistics Network Ltd.
  • Kuehne+Nagel International AG
  • McKesson Corporation
  • Nippon Express Co., Ltd.
  • Schenker AG
  • Schneider National, Inc.
  • SF Express Co., Ltd.
  • United Parcel Service of America, Inc.
  • XPO Logistics, Inc.
Product Code: MRR-563BF1FCF7FA

The Biopharmaceutical Third Party Logistics Market was valued at USD 107.08 billion in 2023, expected to reach USD 121.77 billion in 2024, and is projected to grow at a CAGR of 14.20%, to USD 271.32 billion by 2030.

The biopharmaceutical third-party logistics (3PL) market plays a crucial role in efficiently managing and distributing biopharmaceutical products, providing end-to-end services including warehousing, transportation, and logistics technology tailored for temperature-sensitive and time-critical pharmaceuticals. The necessity of these services is driven by the increasing complexity of the global pharmaceutical supply chain and the need to adhere to stringent regulatory standards while ensuring the safe and efficient delivery of high-value biologics. Applications span across various end-use sectors including hospitals, specialized clinics, and pharmacies, facilitating the distribution of vaccines, monoclonal antibodies, and other biotech drugs. Growth in this market is being fueled by the rising demand for specialty medicines, advancements in logistics technology (like IoT and AI for real-time monitoring), and the expansion of biopharmaceutical production capacities. An emerging opportunity lies in the integration of blockchain for enhanced transparency and security in supply chains, which is increasingly appealing as the industry seeks to mitigate risk and improve compliance. However, the market faces limitations such as high operational costs due to the need for specialized infrastructure and the complexities associated with navigating constantly evolving regulations across different territories. Furthermore, scalability remains challenging due to the niche nature of many biopharmaceuticals requiring tailored storage and transport solutions. Innovation should focus on sustainable logistics solutions aimed at reducing carbon footprint, developing adaptive cold chain solutions, and enhancing data analytics capabilities for predictive logistics planning. The market is inherently competitive, characterized by strategic collaborations and mergers among logistics providers and biopharma companies seeking to optimize distribution networks. Stakeholders should prioritize investments in technology-driven solutions to improve operational efficiency and service differentiation, while also focusing on regional expansion strategies to tap into emerging markets with growing pharmaceutical needs.

KEY MARKET STATISTICS
Base Year [2023] USD 107.08 billion
Estimated Year [2024] USD 121.77 billion
Forecast Year [2030] USD 271.32 billion
CAGR (%) 14.20%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Third Party Logistics Market

The Biopharmaceutical Third Party Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing research and development (R&D) expenditure of pharmaceutical and biopharmaceutical industry
    • Rising need for temperature-controlled logistic services to transport biologics
    • Emerging trend of outsourcing logistics by various medical organizations
  • Market Restraints
    • High costs of drug development and drug discovery procedures
  • Market Opportunities
    • Growing technological advancements in biopharmaceutical third party logistics solutions
    • Rapidly growing need for the biosimilar medicines
  • Market Challenges
    • Stringent governmental rules and regulations for international logistics procedures

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Third Party Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Third Party Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Third Party Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Third Party Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Third Party Logistics Market

A detailed market share analysis in the Biopharmaceutical Third Party Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Third Party Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Third Party Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Third Party Logistics Market

A strategic analysis of the Biopharmaceutical Third Party Logistics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Third Party Logistics Market, highlighting leading vendors and their innovative profiles. These include Agility Public Warehousing Company K.S.C.P, AmerisourceBergen Corporation, C.H. Robinson Worldwide, Inc., CEVA Logistics AG, DB Schenker, DHL International GmbH, FedEx Corporation, Hitachi Transport System, Ltd., Kerry Logistics Network Ltd., Kuehne + Nagel International AG, McKesson Corporation, Nippon Express Co., Ltd., Schenker AG, Schneider National, Inc., SF Express Co., Ltd., United Parcel Service of America, Inc., and XPO Logistics, Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Third Party Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Supply Chain, market is studied across Cold Chain and Non-Cold Chain.
  • Based on Service Type, market is studied across Transportation and Warehousing & Storage. The Transportation is further studied across Air Freight, Overland, and Sea Freight.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research and development (R&D) expenditure of pharmaceutical and biopharmaceutical industry
      • 5.1.1.2. Rising need for temperature-controlled logistic services to transport biologics
      • 5.1.1.3. Emerging trend of outsourcing logistics by various medical organizations
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of drug development and drug discovery procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing technological advancements in biopharmaceutical third party logistics solutions
      • 5.1.3.2. Rapidly growing need for the biosimilar medicines
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent governmental rules and regulations for international logistics procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biopharmaceutical Third Party Logistics Market, by Supply Chain

  • 6.1. Introduction
  • 6.2. Cold Chain
  • 6.3. Non-Cold Chain

7. Biopharmaceutical Third Party Logistics Market, by Service Type

  • 7.1. Introduction
  • 7.2. Transportation
    • 7.2.1. Air Freight
    • 7.2.2. Overland
    • 7.2.3. Sea Freight
  • 7.3. Warehousing & Storage

8. Americas Biopharmaceutical Third Party Logistics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biopharmaceutical Third Party Logistics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biopharmaceutical Third Party Logistics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agility Public Warehousing Company K.S.C.P
  • 2. AmerisourceBergen Corporation
  • 3. C.H. Robinson Worldwide, Inc.
  • 4. CEVA Logistics AG
  • 5. DB Schenker
  • 6. DHL International GmbH
  • 7. FedEx Corporation
  • 8. Hitachi Transport System, Ltd.
  • 9. Kerry Logistics Network Ltd.
  • 10. Kuehne + Nagel International AG
  • 11. McKesson Corporation
  • 12. Nippon Express Co., Ltd.
  • 13. Schenker AG
  • 14. Schneider National, Inc.
  • 15. SF Express Co., Ltd.
  • 16. United Parcel Service of America, Inc.
  • 17. XPO Logistics, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COLD CHAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY NON-COLD CHAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY OVERLAND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING & STORAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 144. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023